Navigation Links
GeoVax Labs Reports 2012 First Quarter Financial Results
Date:5/15/2012

ATLANTA, May 15, 2012 /PRNewswire/ -- GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced its financial results for the three months ended March 31, 2012 and provided a business update.

"We are delighted with recent developments that have strengthened and advanced our HIV/AIDS vaccine program," said Chairman of the Board David Dodd. "Our Phase 1/2 therapeutic vaccine trial continues to enroll patients and we expect full enrollment by the end of 2012. The HIV Vaccine Trials Network (HVTN) continues toward the goal of compiling the data for the Phase 2a trial of our preventive vaccine by the end of 2012 and recently opened a new Phase 1 trial of the next generation of our preventive vaccine, which utilizes granulocyte-macrophase colony-stimulating factor (GM-CSF) as an adjuvant to boost the immune response. We are gratified that the NIH-supported HVTN continues to recognize the potential life-saving value of our vaccine technology and has committed substantial resources toward advancing our clinical progress. Most important, we have a highly competent and dedicated team, focused on excellence in execution related to our ongoing development programs."

Robert T. McNally, PhD, GeoVax President and CEO, remarked, "We are particularly pleased with the outstanding preclinical results we recently reported for our next generation preventive vaccine, which co-expresses GM-CSF as an adjuvant in the DNA vaccine used to prime the immune system. Our studies demonstrated an unprecedented 90% reduction in per exposure risk of transmission for the E660 strain of SIV (simian HIV) and 72% reduction in per exposure risk of transmission for SIV251, the most potent strain of SIV used in non-human primate models. These are extremely rigorous models, with the primates receiving repeated weekly exposures to SIV of up to 300 times the amount one would expect to see in humans. Our data ind
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. GeoVax Labs CEO Update Letter to Shareholders
2. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
3. GeoVax Phase 2a Clinical Trial Completes Enrollment
4. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
5. GeoVax Labs, Inc. Announces Second Quarter Financial Results
6. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
7. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
8. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
9. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
10. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
11. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... Nov. 23, 2014  Aurobindo Pharma USA ... Capsules, USP 300 mg 100-count bottles to the consumer ... some empty capsules. Empty capsules could result ... consequences that could range from no effect, short term ... epilepticus (long period seizures) that could be life-threatening. Aurobindo ...
(Date:11/22/2014)... Nov. 22, 2014  New data demonstrates that flibanserin, ... common form of female sexual dysfunction, Hypoactive Sexual Desire ... driving performance in premenopausal women when taken at bedtime. ... of North America,s (SMSNA) 20th ... . SMSNA accepted this study as ...
(Date:11/22/2014)... Pennsylvania , 21 de noviembre de 2014 ... de ensayos clínicos externalizados y tecnologías eClinical, ha ... aproximación de ,seguimiento inteligente, para el seguimiento basado ... seguimiento inteligente amplía el concepto del seguimiento basado ... reducción de las visitas de seguimiento o cambio ...
Breaking Medicine Technology:Aurobindo Pharma USA, Inc. Issues Voluntary Nationwide Recall of Northstar Label Gabapentin Capsules, USP 300 mg Due to Complaints of Empty Capsules 2Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 2Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 3El 'seguimiento inteligente' consigue un excelente momento 2El 'seguimiento inteligente' consigue un excelente momento 3
... May 3, 2011 Healthcare workers now have the ability ... precautions to better protect themselves, and share information and experiences ... Medical, a segment of BD (Becton, Dickinson and Company) and ... The BD Making Safety Safer(SM) program will provide nurses and ...
... May 3, 2011 Symmetry Medical Inc. (NYSE: ... global orthopaedic device industry and other medical markets, announced today ... Fred L. Hite, Senior Vice President and Chief Financial Officer, ... Merrill Lynch Health Care Conference in Las Vegas, NV. ...
Cached Medicine Technology:Resource Now Available to Help Clinicians Reduce Risk of Blood Exposure from Short Peripheral IV Catheter Insertion 2Resource Now Available to Help Clinicians Reduce Risk of Blood Exposure from Short Peripheral IV Catheter Insertion 3Symmetry Medical to Present at the 2011 Bank of America Merrill Lynch Health Care Conference 2
(Date:11/23/2014)... 2014 (HealthDay News) -- Close friends have more influence ... does, a new study says. "We,ve known ... an influence on individual alcohol use, but there are ... group and the friend group,s influence on those decisions," ... of Public Health, said in a university news release. ...
(Date:11/23/2014)... SWAccessControl.com's high quality access control power suppliers are ... announced its new collection of power suppliers. Additionally, it ... power suppliers. All the new models come with big ... until Dec. 20, 2014. , SWAccessControl.com has thousands of ... it for a long time. It is very wise ...
(Date:11/23/2014)... 23, 2014 The FDA is Watching: ... **FDAnews On-Demand Webinar**, Dec. 11, 2014 ? Any Time ... FDA’s focus on promotional activities is no longer limited ... they're looking at websites, Twitter, journal articles, TV appearances, ... Thursday, Dec. 11, for On-Demand access to Timothy Ayers ...
(Date:11/22/2014)... 23, 2014 Every year AlignLife clinics ... AlignLife experience rapid growth in the Greenville, SC area ... opportunity. AlignLife of Simpsonville will be partnering ... their first annual Toy Drive. These six offices came ... support with this year's toy drive. With so many ...
(Date:11/22/2014)... classic black prom dress will never go out of fashion. ... its new items of black prom gowns . Now ... discount, up to 70% off. People throughout the world can ... dresses, made with the best materials, can make wearers feel ... the company provides these beautiful outfits in a huge range ...
Breaking Medicine News(10 mins):Health News:Close Friends May Be Key to Teens' Drinking 2Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 3Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 5Health News:Greenville Area AlignLife Offices Join Together for a Local Toy Drive 2Health News:New Black Prom Dresses from BellasDress.com 2
... level of seriously ill patients. This has paved the way ... ,A study, published in the open access journal BMC ... software that assists in the ,monitoring of glucose levels in ... more efficient than the paper-based method which is currently used ...
... SMS message that has been doing the rounds in Saudi ... which was reportedly smuggled into the kingdom will harm the ... of Health. ,The medicine provides relief from fever ... been aware of this issue for about 23 days. The ...
... oil supplements for health is well known. These contain the ... to be heart-protective. ,It has been found that DHA ... in the foetus therefore pregnant women should consume it. ... is warranted here as well. In this case, the concern ...
... under threat from a drinking problem. This result is based ... Addictions Research of B.C. compared drinking patterns of the province ... the Canadian Addiction Survey done in 2004. ,The findings ... for alcohol consumption and 53 per cent were above less ...
... Institute of Cardiovascular Disease (GICD) have identified a growth factor ... //therapies for cardiovascular diseases. ,the study, published in ... of Sciences, focuses on the role of short RNAs in ... These RNAs also called as miRNAs, could play a key ...
... the University of Chicago have announced findings of archeological evidence ... B.C., leading to the destruction of a city. Clemens Reichel, ... excavation was conducted was a war zone. Artifacts from daily ... Syria at the Iraqi border. ,The findings ...
Cached Medicine News:Health News:Excavations Reveal Clues Of Early Warfare 2
Tying forceps with flat serrated handle 88 mm, made of titanium, angled 30 with 4.5 mm tying platform....
Thornton titanium curved suture tying forceps, 4"....
Castroviejo McPherson angled tying forceps with 10 mm tips and 5mm titanium coated platforms. Length 110 mm....
Round handle curved tying forceps with 5 mm titanium coated platforms. Length 110 mm....
Medicine Products: